Aerobic exercise training reduces hepatic and visceral lipids in obese individuals without weight loss. 2009

Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
Discipline of Exercise and Sport Science, The University of Sydney, Australia.

Weight loss remains the most common therapy advocated for reducing hepatic lipid in obesity and nonalcoholic fatty liver disease. Yet, reduction of body weight by lifestyle intervention is often modest, and thus, therapies which effectively modulate the burden of fatty liver but are not contingent upon weight loss are of the highest practical significance. However, the effect of aerobic exercise on liver fat independent of weight loss has not been clarified. We assessed the effect of aerobic exercise training on hepatic, blood, abdominal and muscle lipids in 19 sedentary obese men and women using magnetic resonance imaging and proton magnetic resonance spectroscopy ((1)H-MRS). Four weeks of aerobic cycling exercise, in accordance with current physical activity guidelines, significantly reduced visceral adipose tissue volume by 12% (P < 0.01) and hepatic triglyceride concentration by 21% (P < 0.05). This was associated with a significant (14%) reduction in plasma free fatty acids (P < 0.05). Exercise training did not alter body weight, vastus lateralis intramyocellular triglyceride concentration, abdominal subcutaneous adipose tissue volume, (1)H-MRS-measured hepatic lipid saturation, or HOMA-IR (homeostasis model assessment of insulin resistance; P > 0.05). CONCLUSIONS These data provide the first direct experimental evidence demonstrating that regular aerobic exercise reduces hepatic lipids in obesity even in the absence of body weight reduction. Physical activity should be strongly promoted for the management of fatty liver, the benefits of which are not exclusively contingent upon weight loss.

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009765 Obesity A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001835 Body Weight The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. Body Weights,Weight, Body,Weights, Body
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D005230 Fatty Acids, Nonesterified FATTY ACIDS found in the plasma that are complexed with SERUM ALBUMIN for transport. These fatty acids are not in glycerol ester form. Fatty Acids, Free,Free Fatty Acid,Free Fatty Acids,NEFA,Acid, Free Fatty,Acids, Free Fatty,Acids, Nonesterified Fatty,Fatty Acid, Free,Nonesterified Fatty Acids
D005260 Female Females

Related Publications

Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
January 2016, Respiratory physiology & neurobiology,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
February 2000, Perceptual and motor skills,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
March 2012, Nutrition & diabetes,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
October 2017, European journal of applied physiology,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
September 2008, Dynamic medicine : DM,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
January 2009, Journal of applied physiology (Bethesda, Md. : 1985),
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
January 2018, PloS one,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
August 2010, Obesity (Silver Spring, Md.),
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
February 2014, Medicine and science in sports and exercise,
Nathan A Johnson, and Toos Sachinwalla, and David W Walton, and Kate Smith, and Ashley Armstrong, and Martin W Thompson, and Jacob George
July 1996, Journal of applied physiology (Bethesda, Md. : 1985),
Copied contents to your clipboard!